Real Research, Real Results. Together We Can Cure Cancer.

The Sbarro Health Research Organization (SHRO) is a nonprofit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. In 1993, Antonio Giordano, M.D., Ph.D., founded the Sbarro Health Research Organization Institute with a generous donation from Mario Sbarro the Founder of the Sbarro restaurant chain, following Dr. Giordano’s discovery of the tumor suppressor gene pRb2, and cell cycle genes CDK9, CDK10. Initially named the Sbarro Institute, the research center was located at Thomas Jefferson University, where Dr. Giordano was a professor.
Dr. Antonio Giordano - President - Sbarro Health Research Organization - big

Message from Dr. Antonio Giordano – Founder of SHRO

“Think of genetic research as language. We have identified the words; now we are constructing the dictionary and learning the rules of grammar. Our task is to continue assembling the dictionary and perhaps the construction of a few grammatically accurate sentences. The goal is to eventually add new chapters to the novel of life”

Latest Posts

Post & News

Blood Thinners Have Role in Cancer Care to Prevent Embolism

Newswise — Analysis of anticoagulants in patients with malignant cancer shows that further study is needed to establish an adjuvant,…
Read More
Post & News

Virtual Reality Study Reveals Link Between Sense of Presence and Cognitive Abilities

Innovative research explores the impact of sense of presence on cognitive performance in a virtual reality environment. Newswise — (24th…
Read More
Post & News

Deeper Understanding of Malignant Mesothelioma Reveals New Novel Targets to Investigate

Originally published in Newswise Progranulin is a growth factor in cellular activity that is known to play a key role in…
Read More
Post & News

Genetic Oncology Conference Hosted by SHRO at Temple University Connecting Students and Researchers

Newswise — Scientific discoveries on Hereditary Cancer Syndromes have evolved in recent years, with advances in understanding the genetic basis…
Read More
Post & News

Here comes SHRO Italia: At the technological hub of 12,000 Square Meters in the province of Turin

Sbarro Health Research Organization Italia (SHRO Italia) is finally here after its grand opening at Vico Equense and now in…
Read More
Post & News

Barriers to Breast Cancer-Screening in Vulnerable Populations

Newswise — Philadelphia, PA – Women of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.  …
Read More
Post & News

The ‘Research Gala’ for the fight against cancer returns

The Sbarro Health Research Organisation (SHRO), a centre of excellence for cancer research with headquarters in Philadelphia, Pennsylvania, has brought…
Read More
Post & News

Therapy Animals and a Review of the Risk for Zoonotic Transmission

Newswise — Animal-Assisted interventions (AAI) are implemented in hospitals and rehabilitation centers to produce many advantages for the patients but…
Read More
Post & News

Researchers Target Commonly Mutated or Deleted Gene in Gynecological Cancers

Newswise — A gene regulating the F-Box and WD Repeat Domain Containing 7 (FBXW7) protein is frequently mutated or deleted…
Read More
Post & News

Antonio Giordano, M.D., Ph.D. Honored with da Vinci Award by the Italian Heritage and Culture Committee of New York

This blog was originally published in Newswise Members of the Board of Directors of the Italian Heritage and Culture Committee-NY, Inc….
Read More
Post & News

Blood cancers linked to HIV: Insights from recent studies ~ Dr. Antonio Giordano (Sbarro Institute)

This blog was originally published in La Voce Di New York by Prof Antonio Giordano, click here to read in…
Read More
Post & News

New Review Reveals the Critical Role of Progranulin in Cancer

Originally published in Newswise A recent review paper published in the journal Cancers highlights the important role of the growth factor progranulin in…
Read More
Post & News

XVII Conference of Italian Researchers in the World, 1st April 2023

The team of Sbarro Health Research Organization (SHRO) participated in the XVII Conference of Italian Researchers in the World held…
Read More
Post & News

Top US and Italian Researchers Unite for Cutting-Edge Conference on Medicine, Science, and Technology Hosted by SHRO

Originally published in Newswise The Sbarro Health Research Organization (SHRO), led by Prof. Antonio Giordano, in collaboration with the Texas Scientific…
Read More
Post & News

Italia-Usa, AmCham and Consul with successful companies

Originally published in Il Mattino AmCham meets successful companies with ties to the United States, together with Consul Tracy Roberts-Pounds….
Read More
Post & News

SHRO’s Giordano to Speak at Virtual Workshop on Artificial Intelligence in Medicine

Artificial Intelligence and NGS Integrated into the Next Generation Tissue Microarrays (TMA) Workshop Originally published in Newswise Newswise — March…
Read More
Post & News

Cancer: In Italy every year over 8000 patients candidates for liquid biopsy

Rome, 21 February 2023 – Almost 8,000 lung cancer patients are thought to qualify for a liquid biopsy each year…
Read More
Post & News

Malfunctioning Mitochondria at the Heart of Many Cardiovascular Diseases

Newswise Many cardiovascular diseases, such as atherosclerosis, or ‘hardening of the arteries,’ correlate to mitochondrial dysfunction and endothelial impairment in…
Read More
Post & News

Are the Benefits of New Cancer Drugs Worth the Cost?

Newswise — An international research group including scientists from Italy, the United States, Ireland, and Israel have published a three-year…
Read More
Post & News

Links Between Neurological Involvement and Respiratory Damage in SARS-CoV-2 Infection

Newswise — Researchers working with Sbarro Health Research Organization (SHRO) have published a paper examining the possible links between neurological…
Read More
Scroll to Top
Scroll to Top